Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Beckman Coulter, Inc.

Approvalsdevice cleared20 Oct 2026

Beckman Coulter, Inc.

20 Oct 2026: Device cleared · Access BNP II. Recorded in the openFDA device 510(k) data.

View the source record

Decided
20 Oct 2026
Device
Access BNP II
Specialty
Clinical Chemistry
Country
United States
Location
Chaska, MN
Clearance type
Traditional
510(k) number
K262597
Submitted
2026-07-27
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Beckman Coulter, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Beckman Coulter, Inc. in our registers.

More in Clinical Chemistry

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.